SLGC Stock Overview
SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States.
SomaLogic, Inc. Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||US$2.72|
|52 Week High||US$13.25|
|52 Week Low||US$2.58|
|1 Month Change||-1.09%|
|3 Month Change||-31.66%|
|1 Year Change||-77.92%|
|3 Year Change||n/a|
|5 Year Change||n/a|
|Change since IPO||n/a|
Recent News & Updates
|SLGC||US Life Sciences||US Market|
Return vs Industry: SLGC underperformed the US Life Sciences industry which returned -29% over the past year.
Return vs Market: SLGC underperformed the US Market which returned -21.2% over the past year.
|SLGC Average Weekly Movement||11.1%|
|Life Sciences Industry Average Movement||11.4%|
|Market Average Movement||7.4%|
|10% most volatile stocks in US Market||15.6%|
|10% least volatile stocks in US Market||3.3%|
Stable Share Price: SLGC is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 11% a week.
Volatility Over Time: SLGC's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
SomaLogic, Inc. operates as a protein biomarker discovery and clinical diagnostics company in the United States. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate protein; and offers proprietary SomaScan services, which provide multiplex protein detection and quantification of protein levels in complex biological samples. The company’s SOMAmers/SomaScan technology enables researchers to analyze various types of biological samples for protein biomarker signatures, which can be utilized in drug discovery and development.
SomaLogic, Inc. Fundamentals Summary
|SLGC fundamental statistics|
Is SLGC overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|SLGC income statement (TTM)|
|Cost of Revenue||US$96.45m|
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
|Earnings per share (EPS)||-0.44|
|Net Profit Margin||-81.72%|
How did SLGC perform over the long term?See historical performance and comparison